CopyMark Law Group
4.9/5
Drawing for TRANSFORM CARE

USPTO serial 87266925

TRANSFORM CARE

Reviewed by CopyMark Law Group

Reg. 5503999Status 710
Filing date
Status date
Registration date
Jun 26, 2018
Examiner
RICHARDS, LESLIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TRANSFORM CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

ERICH G. RHYNHART CVS Pharmacy, Inc.Mail Code: 1160One CVS DriveWoonsocket, RI 02895-6195

Goods and services

ClassDescriptionStatusFirst use
035Retail pharmacy services; mail order of pharmaceuticals; specialty pharmaceutical distributorship services, namely, distributorships featuring pharmaceuticals; pharmaceutical cost management for the health care benefit plans of others; pharmaceutical utilization review services; prescription drug formulary cost and business management services, namely, clinical and cost-effectiveness reviews following evidence-based medicine and incorporation of value-based criteria into formulary designs; Business administration of pharmacy reimbursement programs and servicesSECTION 8 - CANCELLEDDec 13, 2016
036Pharmacy benefit management services; insurance claims processing of pharmaceutical benefits; Financial administration of pharmacy reimbursement programs and servicesSECTION 8 - CANCELLEDDec 13, 2016
044Therapeutic pharmaceutical services, namely, dispensing of pharmaceuticals and counseling on medications, incorporating disease monitoring services and clinical reviews; Pharmaceutical advice; disease management programsSECTION 8 - CANCELLEDDec 13, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 10, 2025C8..CANCELLED SEC. 8 (6-YR)—
Jun 26, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 26, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 25, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 24, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 9, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 8, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 18, 2018IUAFUSE AMENDMENT FILED—
Apr 18, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 24, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 29, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 29, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 9, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jul 19, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 19, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 19, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 27, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 27, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2017CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jan 12, 2017ALIEASSIGNED TO LIE—
Jan 12, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 12, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 12, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 5, 2017DOCKASSIGNED TO EXAMINER—
Dec 19, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 16, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance